From quarterly updates to key announcements, here you can access all GSK investor-related information.
Scroll to explore
We’re confident in our future
Our bold ambitions for patients are reflected in new commitments to growth and a significant step-change in delivery over the next five years.
Latest announcements and results
2023 First quarter results announcementQuarterly results
We announced our first quarter 2023 results on Wednesday, 26 April.
GSK publishes Prospectus and CircularPress release
We have published the Prospectus and Circular for the proposed demerger of our Consumer Healthcare business to form Haleon.
Completion of the demerger of Haleon and share consolidation of GSKPress release
GSK plc has today completed the demerger of the Consumer Healthcare business from the GSK Group to form the Haleon Group.
Completion of GSK Share ConsolidationPress release
GSK plc is pleased to announce that further to the Circular and Notice of General Meeting published by GSK on 1 June 2022, and following the announcements of 6 July 2022 that shareholder approval was granted at the GSK General Meeting and of 18 July 2022 that GSK has completed the demerger of the Consumer Healthcare business from the GSK Group to form Haleon.
Speeches and presentations
Dividend and share price
ESG Investor Education Event (Clinical Trial Diversity)
Alberto Fernandez, SVP of Global Clinical Operations at GSK and Dr. Kimberly Smith, SVP and Head of R&D at ViiV Healthcare, will provide insights on the importance of clinical trial diversity including support from a 17-year retrospective study. The presentation will be followed by an opportunity for audience Q&A.
Q2 2023 results
We will announce our second quarter 2023 results on Wednesday 26 July.
q3 2023 results
We will announce our third quarter 2023 results on Wednesday 01 November.